Progeria epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
Line 13: Line 13:
*The [[prevalence]] of [[Hutchinson-Gilford progeria syndrome]] ([[HGPS]]) is approximately 1 in 20 million individuals worldwide.
*The [[prevalence]] of [[Hutchinson-Gilford progeria syndrome]] ([[HGPS]]) is approximately 1 in 20 million individuals worldwide.


===Case-fatality rate/Mortality rate===
===Age===
*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
*The case-fatality rate/mortality rate of [disease name] is approximately [number range].


===Age===
*Patients of all age groups may develop [disease name].
*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
*[[Hutchinson-Gilford progeria syndrome]] (HGPS) commonly affects individuals of very younger age rather than older age.
*[[Hutchinson-Gilford progeria syndrome]] (HGPS) commonly affects individuals of very younger age rather than older age.
*The median age at diagnosis is 2.9 years overall.<ref name="pmid168383304">{{cite journal| author=Hennekam RC| title=Hutchinson-Gilford progeria syndrome: review of the phenotype. | journal=Am J Med Genet A | year= 2006 | volume= 140 | issue= 23 | pages= 2603-24 | pmid=16838330 | doi=10.1002/ajmg.a.31346 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16838330  }}</ref>
*The median age at diagnosis is 2.9 years overall.<ref name="pmid168383304">{{cite journal| author=Hennekam RC| title=Hutchinson-Gilford progeria syndrome: review of the phenotype. | journal=Am J Med Genet A | year= 2006 | volume= 140 | issue= 23 | pages= 2603-24 | pmid=16838330 | doi=10.1002/ajmg.a.31346 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16838330  }}</ref>
*[Chronic disease name] is usually first diagnosed among [age group].
*[Acute disease name] commonly affects [age group].


===Race===
===Race===

Revision as of 14:16, 17 July 2019

Progeria Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Progeria from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Progeria epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Progeria epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Progeria epidemiology and demographics

CDC on Progeria epidemiology and demographics

Progeria epidemiology and demographics in the news

Blogs on Progeria epidemiology and demographics

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Progeria epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Epidemiology and Demographics

Incidence

Prevalence

Age

Race

  • [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].

Gender

  • Hutchinson-Gilford progeria syndrome (HGPS) affects men and women equally but males are little more commonly affected by Hutchinson-Gilford progeria syndrome (HGPS) than females. The male to female ratio is approximately 1.2:1.[4]

Region

  • The majority of [disease name] cases are reported in [geographical region].
  • [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].

Developed Countries

Developing Countries

References

  1. Hennekam RC (2006). "Hutchinson-Gilford progeria syndrome: review of the phenotype". Am J Med Genet A. 140 (23): 2603–24. doi:10.1002/ajmg.a.31346. PMID 16838330.
  2. Hennekam RC (2006). "Hutchinson-Gilford progeria syndrome: review of the phenotype". Am J Med Genet A. 140 (23): 2603–24. doi:10.1002/ajmg.a.31346. PMID 16838330.
  3. Hennekam RC (2006). "Hutchinson-Gilford progeria syndrome: review of the phenotype". Am J Med Genet A. 140 (23): 2603–24. doi:10.1002/ajmg.a.31346. PMID 16838330.
  4. Hennekam RC (2006). "Hutchinson-Gilford progeria syndrome: review of the phenotype". Am J Med Genet A. 140 (23): 2603–24. doi:10.1002/ajmg.a.31346. PMID 16838330.

Template:WH Template:WS